These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 4146204

  • 1. Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.
    Svensson TH.
    J Pharm Pharmacol; 1973 Jan; 25(1):73-5. PubMed ID: 4146204
    [No Abstract] [Full Text] [Related]

  • 2. Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.
    Andén NE, Atack CV, Svensson TH.
    J Neural Transm; 1973 Jan; 34(2):93-100. PubMed ID: 4722575
    [No Abstract] [Full Text] [Related]

  • 3. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H, Fuxe K, Lidbrink P.
    Brain Res; 1972 Aug 25; 43(2):397-416. PubMed ID: 4403347
    [No Abstract] [Full Text] [Related]

  • 4. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S.
    Brain Res; 1974 Mar 29; 69(1):57-65. PubMed ID: 4150408
    [No Abstract] [Full Text] [Related]

  • 5. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC, Toon R, Kleinman J, Heller A.
    J Neurochem; 1973 Jan 29; 20(1):69-80. PubMed ID: 4687208
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C, Lundborg P.
    Brain Res; 1973 Oct 26; 61():321-9. PubMed ID: 4149305
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increase of brain levels of tryptophan induced by inhibition of dopamine beta-hydroxylase (EC 1.14.2.1).
    Johnson GA, Kim EG.
    J Neurochem; 1973 Jun 26; 20(6):1761-4. PubMed ID: 4719318
    [No Abstract] [Full Text] [Related]

  • 16. Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.
    Amit Z, Brown ZW, Levitan DE, Ogren SO.
    Arch Int Pharmacodyn Ther; 1977 Nov 26; 230(1):65-75. PubMed ID: 603310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK, Chase TN, Colburn RW, Kopin IJ.
    Neurology; 1972 Jul 26; 22(7):688-96. PubMed ID: 4673250
    [No Abstract] [Full Text] [Related]

  • 19. Effect of an inhibitor of dopamin-beta-hydroxylase on the acquistion and retention of four different avoidance tasks in mice.
    Izquierdo I, Beamish DG, Anisman H.
    Psychopharmacology (Berl); 1979 May 25; 63(2):173-8. PubMed ID: 112636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.